checkAd
    Startseite > Aktien > Nexalin Technology > Nachrichten
    Nexalin Technology Aktie
    0,7000
     
    USD
    -2,79 %
    -0,0201 USD
    Letzter Kurs 02:00:00 Nasdaq
    0,7000
     
    USD
    5.200 STK
    Geldkurs 31.05.24
    0,7150
     
    USD
    500 STK
    Briefkurs 31.05.24
    ISIN: US65345B2016 · WKN: A3DFJP · SYM: NXL · USA

    Neueste Nachrichten

    Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
    22.05.24 · globenewswire · Nexalin Technology
    Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
    09.05.24 · globenewswire · Nexalin Technology
    Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
    25.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology CEO Provides Letter to Shareholders
    10.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Accelerates Manufacturing of its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing
    09.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
    04.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
    02.04.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
    28.03.24 · globenewswire · Nexalin Technology
    Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
    14.03.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
    13.03.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
    06.03.24 · globenewswire · Nexalin Technology
    Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
    08.02.24 · globenewswire · Nexalin Technology